EHA Library - The official digital education library of European Hematology Association (EHA)

3D GENOMICS OF ACUTE MEYLOID LEUKEMIA REVEALS THE IMBALANCE BETWEEN DNA METHYLATION CANYON INTERACTIONS AND LEUKEMIC SPECIFIC ENHANCER NETWORK INTERACTIONS
Author(s): ,
Xiaotian Zhang
Affiliations:
Pathology,The University of Michigan,Ann Arbor,United States;Center for Epigenetics,Van Andel Institute,Grand Rapids,United States
,
David Wang
Affiliations:
Center for Epigenetics,Van Andel Institute,Grand Rapids,United States
,
Fan Feng
Affiliations:
The department of computational medicine,University of Michigan,Ann Arbor,United States
,
Jie Liu
Affiliations:
The department of computational medicine,The University of Michigan,Ann Arbor,United States
Yali Dou
Affiliations:
The University of Southern California,Los Angeles,United States
EHA Library. Zhang X. 06/09/21; 325126; EP372
Xiaotian Zhang
Xiaotian Zhang
Contributions
Abstract
Presentation during EHA2021: All e-poster presentations will be made available as of Friday, June 11, 2021 (09:00 CEST) and will be accessible for on-demand viewing until August 15, 2021 on the Virtual Congress platform.

Abstract: EP372

Type: E-Poster Presentation

Session title: Acute myeloid leukemia - Biology & Translational Research

Background
Changes in 3D chromatin organization like enhancer hijacking are believed to the driver for disease development like leukemia. Here we performed high-resolution HiC assays on primary acute myeloid leukemia (AML) samples and cell lines to dissect the abnormal 3D chromatin organization in AML. We have recently generated a high-resolution map for normal human hematopoietic stem cells (HSC) (Zhang et al. Mole Cell. 2020). 

Aims
To dissect the pathogenic alteration in 3D genomics of acute meyloid leukemia

Methods
We use in situ HiC to generate the high resolution HiC contact map. Our data set covers 5 AML samples and 3 AML cell lines. This dataset includes the common genetic abnormalities in AML: MLL-rearrangement, NPM1 mutation, RUNX1 mutation, and IDH1/TET2 mutations (Figure 1A,B). 

Results

In comparison with the HSC 3D chromatin organization, we found TADs and loops are very stable in both primary leukemia samples and cell lines. Less than 5% of all TADs in HSC without disruption of gene expression for genes located in the fused TAD. Interestingly, in TET2 or IDH1 mutated AML, two-fold more TAD fusion events occurred in comparison with RUNX1 and MLL-r leukemia, with a hypermethylation on the TAD fusion break point regions.


Compared with normal HSC, we found in AML, the AML-specific H3K27ac marked regions form leukemia specific loops and transcription stripes in both cell lines and primary samples. Particularly in MLL-r primary leukemias, we found broad H3K27ac covered, hyperacetylated domains (10kb to 200kb). 22 such hyperacetylated domains were identified and associated with leukemogenic genes such as SATB1ZEB2 and HOXA. All these domains formed distinct 3D micro-TAD in the MLL-r primary leukemia in comparison with the HSPC, and CTCFs are not located at the border of these domains. Taken together, suggest active leukemia specific transcription created new 3D genomic interactions which is independent of cohesion-CTCF mediated loop extrusion. Particularly, we found the driving oncogenic transcriptional factor HOXA9 and MEIS1 is driving the leukemia specific 3D genomic interactions in MLL-AF9 and NPM1 mutant leukemias .


We previously found in HSC, the Polycomb marked DNA methylation Canyons (DMC) form multi-Mb size long-range interactions. DMC interactions in general decrease in primary AMLs. AMLs with IDH1 or TET2 mutations shows the biggest reduction in DMC interactions. Hypermethylation in the DMCs is observed in the all AML samples, but IDH1 and TET2 mutated AML shows the biggest reduction in the H3K27me3 enrichment in DMC regions, suggesting the level of H3K27me3 enrichment is directly correlated with the strength of DMCs. Remarkably, we found some DMCs switched to active state with gain of active chromatin market H3K27ac. Particularly, two Iroquois homeobox genes, which lies in proximity on chromosome 16 - IRX3 and IRX5 are activated in NPM1c leukemia. We found that IRX3 and IRX5 form the long-range stripe interactions with FTO intron enhancer as in the muscle and brain. Further test shows IRX3 and IRX5 is essential for the leukemia growth and the expression is directly maintained by NPM1c in a NPM1c targeted degradation system.

Conclusion
In summary, we have found in AML, specific 3D genomics interactions associated with leukemia specific transcription is established de novo. Particularly, we discovered the DNA methylation Canyon in AML switch from polycomb repressed state to activation state by direct activation of NPM1c.

Keyword(s):

Presentation during EHA2021: All e-poster presentations will be made available as of Friday, June 11, 2021 (09:00 CEST) and will be accessible for on-demand viewing until August 15, 2021 on the Virtual Congress platform.

Abstract: EP372

Type: E-Poster Presentation

Session title: Acute myeloid leukemia - Biology & Translational Research

Background
Changes in 3D chromatin organization like enhancer hijacking are believed to the driver for disease development like leukemia. Here we performed high-resolution HiC assays on primary acute myeloid leukemia (AML) samples and cell lines to dissect the abnormal 3D chromatin organization in AML. We have recently generated a high-resolution map for normal human hematopoietic stem cells (HSC) (Zhang et al. Mole Cell. 2020). 

Aims
To dissect the pathogenic alteration in 3D genomics of acute meyloid leukemia

Methods
We use in situ HiC to generate the high resolution HiC contact map. Our data set covers 5 AML samples and 3 AML cell lines. This dataset includes the common genetic abnormalities in AML: MLL-rearrangement, NPM1 mutation, RUNX1 mutation, and IDH1/TET2 mutations (Figure 1A,B). 

Results

In comparison with the HSC 3D chromatin organization, we found TADs and loops are very stable in both primary leukemia samples and cell lines. Less than 5% of all TADs in HSC without disruption of gene expression for genes located in the fused TAD. Interestingly, in TET2 or IDH1 mutated AML, two-fold more TAD fusion events occurred in comparison with RUNX1 and MLL-r leukemia, with a hypermethylation on the TAD fusion break point regions.


Compared with normal HSC, we found in AML, the AML-specific H3K27ac marked regions form leukemia specific loops and transcription stripes in both cell lines and primary samples. Particularly in MLL-r primary leukemias, we found broad H3K27ac covered, hyperacetylated domains (10kb to 200kb). 22 such hyperacetylated domains were identified and associated with leukemogenic genes such as SATB1ZEB2 and HOXA. All these domains formed distinct 3D micro-TAD in the MLL-r primary leukemia in comparison with the HSPC, and CTCFs are not located at the border of these domains. Taken together, suggest active leukemia specific transcription created new 3D genomic interactions which is independent of cohesion-CTCF mediated loop extrusion. Particularly, we found the driving oncogenic transcriptional factor HOXA9 and MEIS1 is driving the leukemia specific 3D genomic interactions in MLL-AF9 and NPM1 mutant leukemias .


We previously found in HSC, the Polycomb marked DNA methylation Canyons (DMC) form multi-Mb size long-range interactions. DMC interactions in general decrease in primary AMLs. AMLs with IDH1 or TET2 mutations shows the biggest reduction in DMC interactions. Hypermethylation in the DMCs is observed in the all AML samples, but IDH1 and TET2 mutated AML shows the biggest reduction in the H3K27me3 enrichment in DMC regions, suggesting the level of H3K27me3 enrichment is directly correlated with the strength of DMCs. Remarkably, we found some DMCs switched to active state with gain of active chromatin market H3K27ac. Particularly, two Iroquois homeobox genes, which lies in proximity on chromosome 16 - IRX3 and IRX5 are activated in NPM1c leukemia. We found that IRX3 and IRX5 form the long-range stripe interactions with FTO intron enhancer as in the muscle and brain. Further test shows IRX3 and IRX5 is essential for the leukemia growth and the expression is directly maintained by NPM1c in a NPM1c targeted degradation system.

Conclusion
In summary, we have found in AML, specific 3D genomics interactions associated with leukemia specific transcription is established de novo. Particularly, we discovered the DNA methylation Canyon in AML switch from polycomb repressed state to activation state by direct activation of NPM1c.

Keyword(s):

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies